07 Apr FDA’s Final Guidance on Development of Abuse-Deterrent Opioids

Because of the alarming rates seen in opiate and opioid abuse today, the Federal Drug Administration has been working on guidelines to help prescription drug developers in developing opioid drugs that have abuse-deterrent properties. Most recently, the FDA issued a final piece of guidance to assist industry in the form of a document titled "Guidance for Industry: Abuse-Deterrent Opioids - Evaluation and Labeling."
Read More